© ZIMBABWE is set to embrace a new set of medication to fight drug-resistant tuberculosis (DR-TB) following its approval by the United States Food and Drug Administration last week. [GoogleAd] The medication known as BPaL, a combination of TB drugs including pretomanid, bedaquiline, and linezolid was manufactured in South Africa and proved to be effective…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions